STRS Ohio’s Amylyx Pharmaceuticals AMLX Stock Holding History

STRS Ohio’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$251K	Buy	14,000 +10,600	+312%	+$164K	﹤0.01%	1487
2026 Q1	$47.3K	Hold	3,400	–	–	﹤0.01%	1945
2025 Q4	$41.1K	Hold	3,400	–	–	﹤0.01%	2019
2025 Q3	$46.2K	Sell	3,400 -3,900	-53%	-$36.7K	﹤0.01%	2019
2025 Q2	$46.8K	Buy	+7,300	New	+$35.5K	﹤0.01%	2033
2024 Q2	–	Sell	-16,500	Closed	-$46K	–	1956
2024 Q1	$46K	Sell	16,500 -1,000	-6%	-$13.1K	﹤0.01%	1772
2023 Q4	$257K	Buy	+17,500	New	+$268K	﹤0.01%	1497
2023 Q2	–	Sell	-12,300	Closed	-$360K	–	1939
2023 Q1	$360K	Buy	12,300 +7,800	+173%	+$271K	﹤0.01%	1453
2022 Q4	$166K	Buy	4,500 +3,300	+275%	+$117K	﹤0.01%	1626
2022 Q3	$33K	Hold	1,200	–	–	﹤0.01%	1882
2022 Q2	$23K	Sell	1,200 -1,100	-48%	-$13.1K	﹤0.01%	1949
2022 Q1	$29K	Buy	+2,300	New	+$51.9K	﹤0.01%	2008

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jupiter Topco New York $245B AUM

SVCM

Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

STRS Ohio's AMLX Position: Q2 2026 in Review

STRS Ohio increased its Amylyx Pharmaceuticals (AMLX) stake by 312% in Q2 2026, buying an estimated $164K and bringing the position to 14,000 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

STRS Ohio first reported a position in AMLX in Q1 2022 and has held it in 12 quarters since. The position peaked at $360K in Q1 2023. 207 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

STRS Ohio held 14,000 shares of Amylyx Pharmaceuticals worth $251K as of Q2 2026.
STRS Ohio bought 10,600 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $164K.
Amylyx Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1487 holding.
STRS Ohio first reported a position in Amylyx Pharmaceuticals in Q1 2022 and has held it in 12 quarters since.
STRS Ohio's Amylyx Pharmaceuticals position peaked at $360K in Q1 2023.
207 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.